info@myokarditida.cz

Myokarditida

Webový průvodce o nemoci myokarditida, její diagnostice a léčbě.
  • EXPERTS
  • WEB
    • About the web
    • Warning
  • MYOCARDITIS
    • Definition of myocarditis and inflammatory cardiomyopathy (ICMP)
    • Epidemiology
    • Aetiology
    • Pathogenesis
    • Histopathology
  • CLASSIFICATION
    • Classification of myocarditis and ICMP
    • Fulminant, acute and chronic myocarditis
    • Eosinophilic myocarditis
    • Giant-cell myocarditis
    • Cardiac sarcoidosis
    • Myocarditis in HIV positive patients
    • Myocarditis connected with autoimmune diseases
    • Chagas disease
  • DIAGNOSIS
    • Diagnosis generally
    • Subjective symptoms and physical examination
    • ECG and Holter monitoring
    • ECHO and Chest X-Ray
    • Cardiac magnetic resonance imaging (CMRI)
    • Laboratory examination
    • Endomyocardial biopsy (EMB) and nuclear methods and cardiac catheterization
  • TREATMENT
    • Treatment generally
    • Regime measures
    • Heart failure therapy
    • Treatmenf of arrhythmias and thromboembolism
    • Treatment with ATB and antivirotics
    • Immunologial therapy
      • Immunological therapy generally
      • Immunoglobulines
      • Immunoadsorption and interferons
      • Immunosuppressive therapy
    • Mechanical support of inner organs and heart transplant
    • Prognosis
  • OTHER
    • Retrospective study
      • Aims
      • Methods
      • Results
      • Discussion
    • References
    • Abbreviations
    • Contact
Home
/
Profesionální verze
/
Myokarditida

Histopathology

14.3.2017 Jan Habásko

Macroscopic changes of the heart are observed in severe forms of myocarditis when the dilatation of the heart chambers and changes in the myocardial consistence may occur.

The histological finding may be very various. The most common one is lympho…

Více ...

Pathogenesis

14.3.2017 Jan Habásko

The knowledge about myocarditis and ICMP is still limited. It is determined by their varied aetiology and sometimes not quite cleared autoimmune processes which have been detected in myocarditis. Most of the information about the pathogenesis of thes…

Více ...

Aetiology

14.3.2017 Jan Habásko

Aetiology of myocarditis is highly varied (Tab. 1) and includes both infectious and non-infectious agents. The introduction of PCR and electron microscopy for the analysis of bioptically taken samples of the myocardium of patients with myocarditis ha…

Více ...

Epidemiology

14.3.2017 Jan Habásko

The determination of the epidemiology of myocarditis and ICMP is complicated as a result of a lot of factors including primarily challenging diagnosis lacking for now in a single test which would provide sufficient specificity and sensitivity for the…

Více ...

Definition of myocarditis and inflammatory cardiomyopathy (ICMP)

14.3.2017 Jan Habásko

Myocarditis is an inflammatory disease of the myocardium of the focal or diffuse characteristic caused primarily by a viral agent. It is a condition with a varied manifestation and course including asymptomatic cases, new-onset dilated cardiomyopathy…

Více ...

Navigace/Navigation

  • HOME
  • ABOUT
    • About project
    • Warning
    • Stories
      • My story
  • MYOCARDITIS
    • Definition of myocarditis
    • Causes (Etiology)
    • What´s going on in the body (pathogenesis)
    • Symptoms
    • Types of myocarditis
    • Dictionary
  • DIAGNOSIS & TREATMENT
    • Diagnosis
      • Physical examination
      • Electrocardiogram (ECG)
      • X-Ray
      • Echocardiography (ECHO)
      • Cardiac magnetic resonance imaging (CMRI)
      • Lab testing
      • Endomyocardial biopsy (EMB)
      • Scintigraphy and cardiac catheterization
    • Treatment possibilities
      • Treatment possibilities
      • Heart failure treatment
      • Treatment with antivirotics and antibiotics
      • Immunological treatment
      • Other treatment possibilities
    • Life with myocarditis
  • RESEARCH
    • COVID-19
      • COVID-19 (1.část) – úvod
      • COVID-19 (2.část) – příznaky, diagnostika a léčba
      • COVID-19 (3.část) – imunitní systém
      • COVID-19 (4.část) – vakcíny proti SARS-CoV-2
      • COVID-19 (5.část) – imunitní odpověď po nákaze a očkování
      • COVID-19 (6.část) – myokarditida
      • COVID-19 (7.část) – dopady na srdce a cévy
      • COVID-19 (8.část) – dopady infekce
      • COVID-19 novinky 2023 – 1. část
      • COVID-19 novinky 2023 – 2. část
      • COVID-19 – zdroje
    • News
      • Telbivudin
      • Interleukin 1beta inhibitors
      • Rituximab
      • British Heart Foundation
      • Treatment with interferon beta
      • Immunosuppressive therapy of myocarditis
    • What do the Doctors Say?
      • Dr. Renzo Marcolongo
      • Dr. Andrea Silvio Giordani
      • Professor Leslie T. Cooper, Jr.
      • Theodor Adla M.D.
      • Veronika Stará M.D.
      • Lenka Roblová M.D.
  • CONTACT

Kontakty/Contacts

info@myokarditida.cz

Sdílení/Share

  • Facebook
  • Twitter
  • Google+
  • Pinterest
  • LinkedIn
  • Tumblr
  • StumbleUpon
  • Reddit

Sociální sítě/Social networks

Záštita/Patronage

Zpětné odkazy/Links

CZIN.eu TOPlist TOPlist Přidat.eu
Myokarditida © 2026   |